Accordingly, in vitro treatment of Vero or human primary epithelial cells with exogenous sphingosine protected these cells from infection by pseudoviruses expressing the SARS-CoV-2 Spike protein, possibly due to the binding of the exogenous sphingosine to ACE2, hampering Spike’s interaction with its receptor (39). This evidence concerns the gene CHMP5 and infection.